Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 69

1.

Efficacy and safety of T-DM1 in the 'common-practice' of HER2+ advanced breast cancer setting: a multicenter study.

Fabi A, De Laurentiis M, Caruso M, Valle E, Moscetti L, Santini D, Cannita K, Carbognin L, Ciccarese M, Rossello R, Arpino G, Leonardi V, Montemurro F, La Verde N, Generali D, Zambelli A, Scandurra G, Russillo M, Paris I, D'Ottavio AM, Filippelli G, Giampaglia M, Stani S, Fabbri A, Alesini D, Cianniello D, Giannarelli D, Cognetti F.

Oncotarget. 2017 Mar 18. doi: 10.18632/oncotarget.16373. [Epub ahead of print]

2.

Dose intensity and efficacy of the combination of everolimus and exemestane (EVE/EXE) in a real-world population of hormone receptor-positive (ER+/PgR+), HER2-negative advanced breast cancer (ABC) patients: a multicenter Italian experience.

Ciccarese M, Fabi A, Moscetti L, Cazzaniga ME, Petrucelli L, Forcignanò R, Lupo LI, De Matteis E, Chiuri VE, Cairo G, Febbraro A, Giordano G, Giampaglia M, Bilancia D, La Verde N, Maiello E, Morritti M, Giotta F, Lorusso V, Latorre A, Scavelli C, Romito S, Cusmai A, Palmiotti G, Surico G.

Breast Cancer Res Treat. 2017 Jun;163(3):587-594. doi: 10.1007/s10549-017-4213-9. Epub 2017 Mar 28.

PMID:
28353061
3.

O015. Evaluation of the genetic polymorphism of the α3 (CHRNA3) and α5 (CHRNA5) nicotinic receptor subunits, in patients with cluster headache.

Cainazzo MM, Tiraferri I, Ciccarese M, Martinelli A, Cameli C, Bacchelli E, Zoli M, Pini LA.

J Headache Pain. 2015 Dec;16(Suppl 1):A88. doi: 10.1186/1129-2377-16-S1-A88. No abstract available.

4.

Metronomic chemotherapy with oral vinorelbine (mVNR) and capecitabine (mCAPE) in advanced HER2-negative breast cancer patients: is it a way to optimize disease control? Final results of the VICTOR-2 study.

Cazzaniga ME, Cortesi L, Ferzi A, Scaltriti L, Cicchiello F, Ciccarese M, Della Torre S, Villa F, Giordano M, Verusio C, Nicolini M, Gambaro AR, Zanlorenzi L, Biraghi E, Legramandi L, Rulli E; VICTOR Study Group..

Breast Cancer Res Treat. 2016 Dec;160(3):501-509. Epub 2016 Oct 17.

5.

A Delphi consensus and open debate on the role of first-line bevacizumab for HER2-negative metastatic breast cancer.

Puglisi F, Bisagni G, Ciccarese M, Fontanella C, Gamucci T, Leo L, Molino A, Silva RR, Marchetti P.

Future Oncol. 2016 Nov;12(22):2589-2602. doi: 10.2217/fon-2016-0295. Epub 2016 Jul 22.

PMID:
27443691
6.

Prognostic model for advanced breast carcinoma with luminal subtype and impact of hormonal maintenance: Implications for post-progression and conditional survival.

Carbognin L, Sperduti I, Ciccarese M, Fabi A, Petrucelli L, Vari S, Forcignanò RC, Nortilli R, Vicentini C, Pilotto S, Merler S, Zampiva I, Brunelli M, Manfrin E, Giannarelli D, Tortora G, Bria E.

Breast. 2016 Oct;29:24-30. doi: 10.1016/j.breast.2016.06.021. Epub 2016 Jul 7.

PMID:
27394675
7.

Proprotein Convertase Subtilisin Kexin Type 9 Inhibition for Autosomal Recessive Hypercholesterolemia-Brief Report.

Thedrez A, Sjouke B, Passard M, Prampart-Fauvet S, Guédon A, Croyal M, Dallinga-Thie G, Peter J, Blom D, Ciccarese M, Cefalù AB, Pisciotta L, Santos RD, Averna M, Raal F, Pintus P, Cossu M, Hovingh K, Lambert G.

Arterioscler Thromb Vasc Biol. 2016 Aug;36(8):1647-50. doi: 10.1161/ATVBAHA.116.307493. Epub 2016 Apr 14.

PMID:
27079874
8.

Hair analysis to monitor abuse of analgesic combinations containing butalbital and propyphenazone.

Ferrari A, Tiraferri I, Palazzoli F, Verri P, Vandelli D, Marchesi F, Ciccarese M, Licata M.

J Pharm Biomed Anal. 2015 Nov 10;115:576-9. doi: 10.1016/j.jpba.2015.08.015. Epub 2015 Aug 18.

PMID:
26319751
9.

Validation of potential candidate biomarkers of drug-induced nephrotoxicity and allodynia in medication-overuse headache.

Bellei E, Monari E, Bergamini S, Cuoghi A, Tomasi A, Guerzoni S, Ciccarese M, Pini LA.

J Headache Pain. 2015;16:559. doi: 10.1186/s10194-015-0559-8. Epub 2015 Aug 15.

10.

Eribulin in heavily pretreated metastatic breast cancer patients and clinical/biological feature correlations: impact on the practice.

Fabi A, Moscetti L, Ciccarese M, Caramanti M, Salesi N, La Verde N, Russillo M, Generali D, Scandurra G, Vari S, Pacetti U, Cognetti F, Giannarelli D.

Future Oncol. 2015;11(3):431-8. doi: 10.2217/fon.14.271.

PMID:
25675124
11.

Non-pegylated liposome-encapsulated doxorubicin citrate plus cyclophosphamide or vinorelbine in metastatic breast cancer not previously treated with chemotherapy:a multicenter phase III study.

Lorusso V, Giotta F, Bordonaro R, Maiello E, Del Prete S, Gebbia V, Filippelli G, Pisconti S, Cinieri S, Romito S, Riccardi F, Forcignanò R, Ciccarese M, Petrucelli L, Saracino V, Lupo LI, Gambino A, Leo S, Colucci G; Gruppo Oncologico Dell'Italia Meridionale..

Int J Oncol. 2014 Nov;45(5):2137-42. doi: 10.3892/ijo.2014.2604. Epub 2014 Aug 18.

PMID:
25176223
12.

Clinical outcomes and cardiac safety of continuous antiHer2 therapy in c-erbB2-positive metastatic breast cancer patients.

Fedele P, Orlando L, Schiavone P, Ciccarese M, Forcignanò RC, Calvani N, Marino A, Nacci A, Sponziello F, Mazzoni E, Rizzo P, Lorusso V, Cinieri S.

J Chemother. 2013 Dec;25(6):369-75. Epub 2013 Dec 6.

PMID:
24392943
13.

Eribulin in cutaneous breast cancer metastasis treatment: clinical activity and symptom control.

La Verde N, Moretti A, Farina G, Dazzani MC, Gamucci T, Borgonovo K, Botta M, Salesi N, Zuradelli M, Pavese I, Barbieri E, Cretella E, Saladino T, Varese P, Traverso ES, Addamo G, Ciccarese M, Rispoli AI, Pellegrino A, Mentuccia L, Girelli S, Piva S, Di Maio M.

Future Oncol. 2013 Dec;9(12):1841-8. doi: 10.2217/fon.13.216.

PMID:
24295414
14.

Impact of continuing or quitting smoking on episodic cluster headache: a pilot survey.

Ferrari A, Zappaterra M, Righi F, Ciccarese M, Tiraferri I, Pini LA, Guerzoni S, Cainazzo MM.

J Headache Pain. 2013 Jun 6;14:48. doi: 10.1186/1129-2377-14-48.

15.

Discovery by a proteomic approach of possible early biomarkers of drug-induced nephrotoxicity in medication-overuse headache.

Bellei E, Monari E, Cuoghi A, Bergamini S, Guerzoni S, Ciccarese M, Ozben T, Tomasi A, Pini LA.

J Headache Pain. 2013 Jan 30;14:6. doi: 10.1186/1129-2377-14-6.

16.

Epidermal growth factor receptor gene copy number may predict lapatinib sensitivity in HER2-positive metastatic breast cancer.

Fabi A, Merola R, Ferretti G, Di Benedetto A, Antoniani B, Ercolani C, Nisticò C, Papaldo P, Ciccarese M, Sperduti I, Vici P, Marino M, Gori S, Botti C, Malaguti P, Cognetti F, Mottolese M.

Expert Opin Pharmacother. 2013 Apr;14(6):699-706. doi: 10.1517/14656566.2013.779672. Epub 2013 Mar 9.

PMID:
23472669
17.

Nabilone for the treatment of medication overuse headache: results of a preliminary double-blind, active-controlled, randomized trial.

Pini LA, Guerzoni S, Cainazzo MM, Ferrari A, Sarchielli P, Tiraferri I, Ciccarese M, Zappaterra M.

J Headache Pain. 2012 Nov;13(8):677-84. doi: 10.1007/s10194-012-0490-1. Epub 2012 Oct 16.

18.

Comparison of tolerability and efficacy of a combination of paracetamol + caffeine and sumatriptan in the treatment of migraine attack: a randomized, double-blind, double-dummy, cross-over study.

Pini LA, Guerzoni S, Cainazzo M, Ciccarese M, Prudenzano MP, Livrea P.

J Headache Pain. 2012 Nov;13(8):669-75. doi: 10.1007/s10194-012-0484-z. Epub 2012 Oct 2.

19.

[Lyell's syndrome: proposal for a therapeutic protocol].

Posadinu MA, Sanna E, Canu V, Ciccarese M, Pala PG, Cossu M.

G Ital Nefrol. 2012 Jan-Feb;29 Suppl 54:S147-8. Italian.

PMID:
22388849
20.

[LDL-apheresis in patients with familial autosomal recessive hypercholesterolemia].

Pala P, Loriga G, Carassino A, Ciccarese M, Ulgheri L, Farina A, Re F, Cossu M.

G Ital Nefrol. 2012 Jan-Feb;29 Suppl 54:S135-7. Italian.

PMID:
22388845

Supplemental Content

Loading ...
Support Center